Wednesday Jul 23
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014
We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people.
US stocks rebound as Google jumps while Ukraine concerns ease
U.S. stocks jumped, with the Standard & Poor's 500 Index rebounding from its worst drop since April, as Google rose after sales beat analysts' estimates and concerns eased over crises in the Ukraine and Middle East.
Johnson & Johnson Spinout Zosano Pharma, Inc. Sets Terms For $70 Million IPO
Zosano Pharma, a biotech developing a transdermal delivery system to treat osteoporosis, announced terms for its IPO on Wednesday.
Three Documentary Films All Progressives Should See, Learn & Memorize
As part of another diary I brought up several excellent sources of Truth, Reality and Knowledge and today I re-post that information purely for it's own sake because I truly believe - it's worth the effort and benefit that it may impart to all those who are willing to listen and capable of comprehending the message.
Customer Interaction Solutions
Medivir: Continued strong market uptake for OLYSIO during the second quarter 2014
Medivir AB announces that the global second quarter net sales of Olysio amounted to 831 MUSD, of which 725 MUSD were sales in the USA.
Wall Street Journal
Johnson & Johnson's Results Lifted by Hep C Drug
Johnson & Johnson said Tuesday that its second-quarter earnings grew as sales of the company's new hepatitis C drug continued to boost the health-care giant's revenue.
The Washington Post
Spinversions Make Giants Candidates to Escape U.S. Tax: Real M&A
American conglomerates that want a piece of the tax-inversion deal bonanza may start turning to a new tactic.
Oxford BioTherapeutics Appoints As Head Of Clinical Development
Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug conjugates for the treatment of cancer, announced today the appointment of Eugen Leo, MD, PhD, MBA, as Head of Clinical Development.
Kony Appoints Two Industry Luminaries to Complete Executive Team
Check out our press release hub , powered by Business Wire. It's a one stop shop for industry announcements to help you stay on top of the latest technology and investment trends.
XLV, UCD: Big ETF Inflows
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the Health Care Select Sector SPDR Fund , which added 11,000,000 units, or a 7.1% increase week over week.